Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28447955 | 0.76 | GRIK1 (0.34) | GRIK1 | |
| SCHEMBL4447283 | 0.75 | — | — | |
| SCHEMBL28616265 | 0.75 | GRIK1 (0.30) | GRIK1 | |
| SCHEMBL4447287 | 0.75 | — | — | |
| SCHEMBL8192839 | 0.75 | GRIK1 (0.30) | GRIK1 | |
| SCHEMBL448514 | 0.74 | CD81 (0.30) | — | |
| SCHEMBL3880563 | 0.74 | GRIK1 (0.32) | GRIK1 | |
| SCHEMBL4040653 | 0.74 | GRIK1 (0.32) | GRIK1 | |
| SCHEMBL3880569 | 0.74 | GRIK1 (0.32) | GRIK1 | |
| SCHEMBL2808090 | 0.74 | GRIK1 (0.32) | GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100210812-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | SHOWA DENKO K.K. (JP) | 2010-08-19 | — | — | US | disclosed |
| US-20100087611-A1 | URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT THEREOF | SHOWA DENKO K.K. (JP) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087611-A1 | URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT THEREOF | ITCH, GLI1, UNC119 | GRIK1 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.